thromboxanes has been researched along with Hyperglycemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Hein, TW; Kuo, L; Rosa, RH; Xu, W | 1 |
| Harris, NR; Lee, S | 1 |
| Bell, TD; Brands, MW; Panteleyev, D; Polavarapu, P; Rodriquez, NA | 1 |
| Anfossi, G; Barale, C; Cavalot, F; Doronzo, G; Mattiello, L; Pagliarino, A; Russo, I; Trovati, M; Viretto, M | 1 |
| Abram, SR; Carter, C; Dearman, J; Hester, RL; Xiang, L | 1 |
| Daniels, BS | 1 |
6 other study(ies) available for thromboxanes and Hyperglycemia
| Article | Year |
|---|---|
Hyperglycemia Enhances Constriction of Retinal Venules via Activation of the Reverse-Mode Sodium-Calcium Exchanger.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Endothelin-1; Hyperglycemia; Male; Real-Time Polymerase Chain Reaction; Retina; Sodium-Calcium Exchanger; Swine; Thromboxanes; Vasoconstriction; Vitreous Body | 2019 |
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Blood Flow Velocity; Constriction, Pathologic; Female; Fibrinolytic Agents; Hyperglycemia; Losartan; Methacrylates; Mice; Mice, Inbred NOD; Retinal Vessels; Thromboxanes; Venules | 2008 |
Chronic glucose infusion causes sustained increases in tubular sodium reabsorption and renal blood flow in dogs.
Topics: Animals; Blood Glucose; Blood Pressure; Disease Models, Animal; Dogs; Glomerular Filtration Rate; Glucose; Hyperglycemia; Hyperinsulinism; Hypertension; Infusions, Intravenous; Insulin; Kidney Tubules; Male; Natriuresis; Nephrectomy; Prostaglandins; Regional Blood Flow; Renal Circulation; Renin; Sodium; Sodium Chloride, Dietary; Thromboxanes; Time Factors; Vascular Resistance; Vasodilation | 2009 |
High glucose inhibits the aspirin-induced activation of the nitric oxide/cGMP/cGMP-dependent protein kinase pathway and does not affect the aspirin-induced inhibition of thromboxane synthesis in human platelets.
Topics: Adult; Amifostine; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Drug Resistance; Female; Humans; Hyperglycemia; Lysine; Male; Microfilament Proteins; Nitric Oxide; Phosphoproteins; Phosphorylation; Platelet Aggregation Inhibitors; Protein Processing, Post-Translational; Second Messenger Systems; Thromboxanes; Vasodilator Agents; Young Adult | 2012 |
Insulin resistance and impaired functional vasodilation in obese Zucker rats.
Topics: Animals; Antioxidants; Arachidonic Acid; Arterioles; Blood Glucose; Bridged Bicyclo Compounds, Heterocyclic; Cyclic N-Oxides; Disease Models, Animal; Electric Stimulation; Fatty Acids, Unsaturated; Hydrazines; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Insulin; Insulin Resistance; Kidney Cortex; Male; Muscle, Skeletal; NADPH Oxidases; Obesity; Oxidative Stress; Rats; Rats, Zucker; Receptors, Thromboxane; Rosiglitazone; Spin Labels; Superoxides; Thiazolidinediones; Thromboxanes; Time Factors; Triglycerides; Vasoconstriction; Vasodilation | 2008 |
Regional versus systemic modulation of the microcirculation in diabetes mellitus.
Topics: Capillary Permeability; Diabetic Angiopathies; Diabetic Nephropathies; Hemodynamics; Humans; Hyperglycemia; Microcirculation; Renin-Angiotensin System; Thromboxanes | 1993 |